The Usefulness of FEF25–75 in Predicting Airway Hyperresponsiveness to Mannitol
Open Access
- 1 October 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 14, 1267-1275
Abstract
Background and Objective: Despite the usefulness of airway hyperresponsiveness (AHR) testing in diagnosing and monitoring asthma, it is challenging to perform in a real-world setting. Forced expiratory flow between 25% and 75% of vital capacity (FEF25– 75), a pulmonary measurement that can be obtained easily during routine spirometry, represents the status of medium-sized and small airways. However, the performance of FEF25– 75 in predicting AHR has not been well elucidated. Therefore, we investigated whether FEF25– 75 can predict AHR to mannitol. Methods: We performed a retrospective cohort study of 428 patients who visited a single clinic due to cough, wheezing, or dyspnea. All patients underwent spirometry with a mannitol provocation test. We compared the area under the curve (AUC) of the percentage of the predicted values of FEF25– 75 (FEF25– 75 %pred) with that of forced expiratory volume in 1 second (FEV1%pred), FEV1/forced vital capacity (FVC), and FEF25– 75/ FVC for predicting AHR. Results: The rate of AHR to mannitol was 20.3%. In the overall study population, the AUC of FEF25– 75 %pred for predicting AHR (0.772; 95% confidence interval [CI], 0.729– 0.811) was significantly higher than that of FEV1%pred (0.666; 95% CI, 0.619– 0.710; p < 0.001), FEV1/FVC (0.741; 95% CI, 0.697– 0.782; p = 0.047), and FEF25– 75/FVC (0.741, 95% CI = 0.696– 0.782, p = 0.046). The sensitivity, specificity, positive predictive value, and negative predictive value of FEF25– 75 %pred < 81% for predicting AHR in the overall study population were 77.0% (95% CI = 66.8– 85.4%), 63.9% (95% CI = 58.6– 69.0), 35.3%, and 91.6%, respectively. When we restricted the study group to subjects with normal lung function, the results were similar. Conclusion: Our results indicate that FEF25– 75 %pred can be used as a surrogate for predicting AHR in patients with respiratory symptoms.Keywords
This publication has 21 references indexed in Scilit:
- Measurement of FEF25–75%and FEF75%does not contribute to clinical decision makingEuropean Respiratory Journal, 2013
- The interest of FEF25–75 in evaluating bronchial hyperresponsiveness with the methacholine testAllergologia et Immunopathologia, 2012
- The Utility of Forced Expiratory Flow between 25% and 75% of Vital Capacity in Predicting Childhood Asthma Morbidity and SeverityJournal of Asthma, 2012
- Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnnals of Internal Medicine, 2011
- Forced expiratory flow between 25% and 75% of vital capacity may be a marker of bronchial impairment in allergic rhinitisJournal of Allergy and Clinical Immunology, 2011
- Indirect Challenge TestsChest, 2010
- Youden Index and the optimal threshold for markers with mass at zeroStatistics in Medicine, 2007
- Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2004
- Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in childrenJournal of Allergy and Clinical Immunology, 2003
- A New Method For Bronchial-provocation Testing in Asthmatic Subjects Using a Dry Powder of MannitolAmerican Journal of Respiratory and Critical Care Medicine, 1997